ANGIODYNAMICS INC 4
4 · ANGIODYNAMICS INC · Filed Jul 29, 2014
Insider Transaction Report
Form 4
Bourne George W. IV
SVP and CTO
Transactions
- Award
Performance Right
2014-07-25+7,125→ 7,125 total→ Common Stock (7,125 underlying) - Award
Common Stock
2014-07-25+5,344→ 24,187 total - Award
Non-Qualified Stock Option (right to buy)
2014-07-25+15,377→ 15,377 totalExercise: $14.07From: 2015-08-03Exp: 2021-07-25→ Common Stock (15,377 underlying)
Footnotes (4)
- [F1]This acquisition of 5,344 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 5,344 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on August 3, 2015, such that 25% of the restricted stock units will vest on each of August 3, 2015, 2016, 2017 and 2018.
- [F2]Includes 1,936 shares of Common Stock acquired under the AngioDynamics, Inc. Employee Stock Purchase Plan on February 28, 2014.
- [F3]These stock options vest in four equal annual installments beginning on August 3, 2015, such that 25% of the options will vest on each of August 3, 2015, 2016, 2017 and 2018.
- [F4]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2015, 2016 and 2017. Any shares that do not vest at the end of the performance period will be forfeited.